Search Results for: IPS cell

Stem cell & regenerative medicine news: cool pubs, people, ARM, & more

Tanabe-Figure-1B

How does one keep up with all the regenerative medicine and stem cell happenings? There is always something happening in the stem cell and regenerative medicine field ranging from science to policy matters. This post is an update on some recent stem cell happenings that I see as notable or interesting. New Pubs Direct reprogramming […]

Stem cell & regenerative medicine news: cool pubs, people, ARM, & more Read More »

10 questions on FDA suits targeting stem cell clinics

SVF2

The FDA via the DOJ has sued to get permanent injunctions against US Stem Cell, Inc. (USRM) and California Stem Cell Treatment Center/Cell Surgical Network (CSN). Both firms use an unapproved fat stem cell product in patients called stromal vascular fraction (the SVF production process is pictured at right) that the FDA indicates is generally

10 questions on FDA suits targeting stem cell clinics Read More »

TV Journalists Tackling Stem Cell Clinics

CBS-This-Morning-TV-segment-Stem-Cells

Even as some unproven, for-profit stem cell clinics promote themselves aggressively in many ways including now on TV, on the flip side lately we’ve seen more TV journalists covering questionable marketing by the clinics and negative patient outcomes. Today I saw that CBS This Morning, a national broadcast, had a fairly long TV segment on stem

TV Journalists Tackling Stem Cell Clinics Read More »

15 still unanswered interview questions for stem cells for vision SCOTS trial docs

George-Gibson-SCOTS-patient-screenshot-of-Sun-Sentinel-video-1

What is the SCOTS Trial and why are some of its participants raising concerns? There’s a lot going on in Florida with non-FDA approved stem cell offerings. Even just related to stem cells for vision problems alone. While US Stem Cell has drawn the most attention related to patient allegations of severe vision loss in Florida

15 still unanswered interview questions for stem cells for vision SCOTS trial docs Read More »

Tarek El Moussa stem cell shot, a flip or a flop? Risks of celeb buzz

Tarek-El-Moussa-stem-cells

The world is constantly bombarded these days with often-hyped stories of the latest celebrities who got unproven stem cells, including most recently Jack Nicklaus and now Tarek El Moussa of Flip or Flop TV real estate fame. Both these celebs got stem cells for orthopedic kind of health situations, but while in theory stem cells

Tarek El Moussa stem cell shot, a flip or a flop? Risks of celeb buzz Read More »

When the fat stem cells hit the fire, will clinics sued by FDA opt to stop soon?

when-the-fat-hits-the-fire-stem-cells

Will the adipose stem cell clinic firms facing permanent injunction suits by the FDA — U.S. Stem Cell Inc. (USRM) and California Stem Cell Treatment Center (CSCTC)/Cell Surgical Network (CSN) — cool it in the sense of voluntarily shutting down their commercial fat stem cell injections of customers soon pending the outcomes of the suits?

When the fat stem cells hit the fire, will clinics sued by FDA opt to stop soon? Read More »

Update on state laws on stem cell clinics: California, Washington, & Florida

washington-state-stem-cells-law

California broke new ground with our stem cell law that went into effect on January 1. It requires stem cell clinic firms to post notices informing patients of important information such as the fact that their offerings are non-FDA approved. At this point, 4+ months into the enforcement period, I’m not sure if anyone has

Update on state laws on stem cell clinics: California, Washington, & Florida Read More »

Helpful Zettler insights from Q&A on FDA suits against stem cell clinics

Patti-Zettler

At the request of the FDA, the DOJ is suing for permanent injunctions against two stem cell clinic firms, U.S. Stem Cell, Inc. and California Stem Cell Treatment Center (and for the latter, its parent chain of around 100 clinics, Cell Surgical Network). What does this big development mean in practical terms and how might it

Helpful Zettler insights from Q&A on FDA suits against stem cell clinics Read More »